Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Gastroenterology|July 19, 2017
Dynamics of Proliferative and Quiescent Stem Cells in Liver Homeostasis and InjuryWanlu Cao, Kan Chen, Michiel Bolkestein, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 29, 2024
Holmium-166 radioembolisation dosimetry in HCCMargot T M Reinders, Arthur J A T Braat, Karel J van Erpecum, et al.
Scientific Reports|May 7, 2016
Convergent Transcription of Interferon-stimulated Genes by TNF-α and IFN-α Augments Antiviral Activity against HCV and HEVWenshi Wang, Lei Xu, Johannes H Brandsma, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2020
Trends in incidence, diagnosis, treatment and survival of hepatocellular carcinoma in a low-incidence country: Data from the Netherlands in the period 2009-2016Margot T M Reinders, Suzanne van Meer, Mark C Burgmans, et al.
Oncoimmunology|June 15, 2018
Blockade of LAG3 enhances responses of tumor-infiltrating T cells in mismatch repair-proficient liver metastases of colorectal cancerGuoying Zhou, Lisanne Noordam, Dave Sprengers, et al.
Cellular and Molecular Gastroenterology and Hepatology|March 30, 2021
TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8<sup>+</sup> T Cells in Hepatocellular CarcinomaZhouhong Ge, Guoying Zhou, Lucia Campos Carrascosa, et al.
International Journal of Cancer|February 6, 2019
GITR ligation enhances functionality of tumor-infiltrating T cells in hepatocellular carcinomaAdriaan A van Beek, Guoying Zhou, Michail Doukas, et al.
Cancers|November 13, 2021
Liver Decompensation as Late Complication in HCC Patients with Long-Term Response following Selective Internal Radiation TherapyDiederick J van Doorn, Pim Hendriks, Mark C Burgmans, et al.
Antiviral Research|July 30, 2016
Mycophenolic acid potently inhibits rotavirus infection with a high barrier to resistance developmentYuebang Yin, Yijin Wang, Wen Dang, et al.
British Journal of Cancer|May 21, 2022
Modelling immune cytotoxicity for cholangiocarcinoma with tumour-derived organoids and effector T cellsGuoying Zhou, Ruby Lieshout, Gilles S van Tienderen, et al.
Pageof 9